Alcon has announced new product launches in the U.S. as well as activities taking place at the American Academy of Ophthalmology (AAO) 2022 annual meeting in Chicago.
Alcon introduces Clareon Toric IOL at AAO and completes the Clareon Collection
With the introduction of Clareon® Toric intraocular lens (IOL), Alcon offers a robust portfolio of options for U.S. cataract patients with astigmatism on its latest, glistening-free* material.1-3 Clareon Toric features unique and proven STABLEFORCE® Haptics technology, with demonstrated superior rotational and axial stability when compared to TECNIS† and enVista.4,5†**
Clareon Toric and Clareon Monofocal consistently deliver a broad refractive landing zone, providing functional intermediate vision while maintaining the expected 20/20 visual acuity at distance.6-8 The Clareon Collection of IOLs is now complete and includes Clareon Monofocal, Clareon Toric, Clareon PanOptix®, Clareon PanOptix Toric, Clareon Vivity® and Clareon Vivity Toric—all available in UV-absorbing and blue light filtering foldable options in the U.S.
“When deciding which lens to recommend to my patients, I like to have a toolbox of versatile options that provide consistent, predictable outcomes—and the Clareon Collection of IOLs offers exactly that,” said Kerry Solomon, MD.§ “Now, with the availability of Clareon Toric, I am able to offer my patients a glistening-free,* astigmatism-correcting option for them during surgery.”
Expanding Alcon’s digital offerings with Fidelis, and patient engagement
Fidelis™ Virtual Reality Ophthalmic Surgical Simulator, which was introduced in select markets in May, is now available for pre-order for customers in the U.S. Fidelis offers a high-fidelity, virtual operating room environment with haptic feedback to simulate the look and feel of cataract surgery, helping new surgeons hone their skills.9,10
“Partnering with ophthalmologists to develop world-class solutions that help drive optimal outcomes is in our DNA—and we would not be able to deliver digital innovations without these trusted relationships,” said Sergio Duplan, Region President Alcon North America. “At AAO, we are proud to showcase our cloud-based connected technologies with ARGOS®, the fastest growing biometer in the U.S., as well as other key offerings like a text-driven patient engagement tool with demonstrable ROI for ophthalmology practices.” 11,12
The need for remote, digital solutions in ophthalmology has never been greater, given worldwide surgery backlogs and staffing shortages. Alcon is committed to shaping digital transformation in ophthalmology. In addition to the opportunity to demo Fidelis, surgeons will be able to experience and sign up for a resource that educates cataract patients about surgery and advanced technology IOL options via SMS text. These activities will take place at Alcon booth #3926 at the AAO exhibit hall, on Oct. 1-3 from 9:00 a.m.–5:00 p.m. Central Time.
Data highlight benefits of Alcon surgical ophthalmic products
Key studies being presented on Alcon products include:
- Global registry data in more than 750 patients surrounding AcrySof® IQ Vivity® IOL supports continued patient satisfaction, low instances of visual disturbances and reduced spectacle dependence.13
- Results from a multicenter, prospective clinical trial demonstrates energy and surgical time savings when using the CENTURION® phacoemulsification system with Active Sentry®.14
- A novel retina imaging technique using the NGENUITY® 3D Visualization System unveiled by surgeons seeking to develop more efficient methods for fluorescein angiography.15
- A clinical study of 500 eyes comparing results of CONTOURA® Laser Vision Correction with Phorcides Analytic Engine in low versus high myopia.16
Read the full press release from Alcon.